Skip to main content

Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study.

Publication ,  Journal Article
Rudolph, DA; Hald, SM; García Rodríguez, LA; Möller, S; Hallas, J; Goldstein, LB; Gaist, D
Published in: Neurology
August 15, 2022

BACKGROUND AND OBJECTIVES: A causal relationship between long-term statin use and the risk of intracerebral hemorrhage (ICH) remains uncertain. We investigated the association with statin use before hospital admission for ICH in a Danish population-based, nationwide case-control study. METHODS: We used the Danish Stroke Registry to identify all patients aged 45 years or older with a first-ever ICH between 2005 and 2018. Patients with ICH were matched for age, sex, and calendar year to controls selected from the general population. A medication registry with information on all dispensed prescriptions at community pharmacies in Denmark since 1995 was used to ascertain previous statin exposure that was classified for recency, duration, and intensity. Using conditional regression and adjusting for potential confounders, we calculated adjusted odds ratios (aORs) and corresponding 95% CIs for the risk of ICH. RESULTS: The study population consisted of 16,235 patients with ICH and 640,943 controls. Current statin use (cases 25.9% vs controls 24.5%; aOR 0.74, 95% CI, 0.71-0.78) and a longer duration of current statin use (<1 year: aOR 0.86; 95% CI, 0.81-0.92; ≥1 to <5 years: aOR 0.72; 95% CI, 0.68-0.76; ≥5 to <10 years: aOR 0.65; 95% CI, 0.60-0.71; ≥10 years of use, 0.53; 95% CI 0.45-0.62; p for trend <0.001) were associated with a lower risk of ICH. Similar treatment duration relationships were found in analyses stratified by statin use intensity (high-intensity therapy: <1 year of use: aOR 0.78; 95% CI, 0.66-0.93; ≥10 years of use: aOR 0.46; 95% CI 0.33-0.65; p for trend 0.001). DISCUSSION: We found that a longer duration of statin use was associated with a lower risk of ICH. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that current statin use and a longer duration of statin use are each associated with a lower risk of ICH.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

August 15, 2022

Volume

99

Issue

7

Start / End Page

e711 / e719

Location

United States

Related Subject Headings

  • Stroke
  • Neurology & Neurosurgery
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Denmark
  • Cerebral Hemorrhage
  • Case-Control Studies
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rudolph, D. A., Hald, S. M., García Rodríguez, L. A., Möller, S., Hallas, J., Goldstein, L. B., & Gaist, D. (2022). Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study. Neurology, 99(7), e711–e719. https://doi.org/10.1212/WNL.0000000000200713
Rudolph, Daniel Albjerg, Stine Munk Hald, Luis Alberto García Rodríguez, Sören Möller, Jesper Hallas, Larry B. Goldstein, and David Gaist. “Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study.Neurology 99, no. 7 (August 15, 2022): e711–19. https://doi.org/10.1212/WNL.0000000000200713.
Rudolph DA, Hald SM, García Rodríguez LA, Möller S, Hallas J, Goldstein LB, et al. Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study. Neurology. 2022 Aug 15;99(7):e711–9.
Rudolph, Daniel Albjerg, et al. “Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study.Neurology, vol. 99, no. 7, Aug. 2022, pp. e711–19. Pubmed, doi:10.1212/WNL.0000000000200713.
Rudolph DA, Hald SM, García Rodríguez LA, Möller S, Hallas J, Goldstein LB, Gaist D. Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage: A Danish Nationwide Case-Control Study. Neurology. 2022 Aug 15;99(7):e711–e719.

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

August 15, 2022

Volume

99

Issue

7

Start / End Page

e711 / e719

Location

United States

Related Subject Headings

  • Stroke
  • Neurology & Neurosurgery
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Denmark
  • Cerebral Hemorrhage
  • Case-Control Studies
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences